New hope for hard-to-treat bone cancer: experimental drug enters human testing
NCT ID NCT07297979
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 24 times
Summary
This early-stage trial is testing a new drug called xaluritamig in about 50 people with Ewing sarcoma, a rare bone cancer, that has returned or stopped responding to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will also measure how the drug moves through the body and whether it helps control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
-
Chris OBrien Lifehouse
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Perth Childrens Hospital
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
University of California Los Angeles
RECRUITINGLos Angeles, California, 90995-1752, United States
Conditions
Explore the condition pages connected to this study.